Concepedia

Helen N. Pemberton

HN

Statistics

Publications

24

Citations

4.7K

H-Index

21

Active since

2003

Affiliations

Breast Cancer Now(Current)

Institute of Cancer Research

CRUK Lung Cancer Centre of Excellence

University of Birmingham

University College London

Helen N. Pemberton is an author at Breast Cancer Now specializing in molecular oncology, medicine, and oncology.

Publications per year

2003–2023

24

Publications

24

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu et al. · New England Journal of Medicine · 2015 · 2.2K citations · Full text

, , +17

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance

Stephen J. Pettitt, Dragomir B. Krastev, Inger Brandsma et al. · Nature Communications · 2018 · 447 citations · Full text

, , +17

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A

Chris T. Williamson, Rowan Miller, Helen N. Pemberton et al. · Nature Communications · 2016 · 387 citations · Full text

, , +17

MicroRNA Regulation of Cbx7 Mediates a Switch of Polycomb Orthologs during ESC Differentiation

Ana O’Loghlen, Ana M. Muñoz-Cabello, Alexandre Gaspar‐Maia et al. · Cell stem cell · 2012 · 200 citations · Full text

, , +17

Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration

Benedetta Bussolati, Asif Ahmed, Helen N. Pemberton et al. · Blood · 2003 · 197 citations · Full text

, , +15

1–5 of 24